Nextage Therapeutics Ltd
Tel Aviv Stock Exchange NXTG.TA
Nextage Therapeutics Ltd Gross Profit Margin for the year ending December 31, 2023: 25.68%
Nextage Therapeutics Ltd Gross Profit Margin is 25.68% for the year ending December 31, 2023. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
-
Nextage Therapeutics Ltd Gross Profit Margin for the year ending December 31, 2021 was 17.58%, a -9.24% change year over year.
-
Nextage Therapeutics Ltd Gross Profit Margin for the year ending December 31, 2020 was 19.37%, a -72.21% change year over year.
-
Nextage Therapeutics Ltd Gross Profit Margin for the year ending December 31, 2019 was 69.70%, a -9.82% change year over year.
Key data
| Date | Gross Profit Margin | Operating Income Margin | EBT Margin | Net Income Margin |
|---|
Market news
Loading...
Tel Aviv Stock Exchange: NXTG.TA
| CEO | Mr. Abraham Dreazen |
| IPO Date | Aug. 12, 2002 |
| Location | Israel |
| Headquarters | Einstein St. Building 13B |
| Employees | 42 |
| Sector | Health Care |
| Industries | |
Description
Nextage Therapeutics Ltd develops cannabinoid-based products. The company is based in Ness Ziona, Israel.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email